Trademark Overview
On Thursday, September 5, 2024, a trademark application was filed for ARAMIS BIOTECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the ARAMIS BIOTECHNOLOGIES trademark a serial number of 79410370. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, April 15, 2025. This trademark is owned by Biotechnologies Aramis inc.. The ARAMIS BIOTECHNOLOGIES trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Custom manufacture of pharmaceuticals, pharmaceutical ingredients and human vaccines, custom manufacturing of pharmaceuticals, pharmaceutical ingredients and human vaccines.
Pharmaceutical and medicinal preparations and substances, namely, vaccines; pharmaceutical and medicinal preparations and substances, namely, recombinant proteins.
Medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccines; on-line information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccines.
Research and development in the field of human vaccines; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients and human vaccines; medical and scientific research regarding clinical trial studies on new vaccine candidates.
